Priority Health Partners With GRAIL to Offer Galleri Multi-Cancer Early Detection Test

Priority Health has partnered with GRAIL (Nasdaq: GRAL) to offer the Galleri® multi-cancer early detection blood test as part of its employer plans in Michigan. This collaboration marks Priority Health's expansion beyond Medicare Advantage coverage, making it the first health plan in Michigan to integrate this advanced screening option for self-insured employers.

By GRAIL, Inc. · PR Newswire · July 16, 2026, 13:00 UTC

Tickers: $GRAL

Topics: cancer detection collaboration insurance coverage multi-cancer early detection (MCED)

Read the full article at PR Newswire

More Health news

Eli Lilly Shares Rise Following Positive Clinical Trial Results for Retatrutide and Foundayo Motley Fool · November 12, 2026, 17:15 UTC
Data Suggests United States May Lose Measles Elimination Status The Verge · November 11, 2026, 19:48 UTC
Rising U.S. Measles Outbreaks Pose Significant Economic Burden CNBC · November 11, 2026, 12:00 UTC
FDA Issues Not Approvable Letter for NovoCure's Optune Mya Motley Fool · November 10, 2026, 18:50 UTC
Immunovant Reports Q2 2026 Financial Results and IMVT-1402 Clinical Data Motley Fool · November 10, 2026, 01:43 UTC
Royalty Pharma Poised to Benefit from Revolution Medicines' FDA-Approved Pancreatic Cancer Drug Motley Fool · November 8, 2026, 15:15 UTC
Acumen Pharmaceuticals Expects Phase II Alzheimer's Trial Results in November 2026 Motley Fool · November 5, 2026, 01:48 UTC
Moderna and Merck Face Manufacturing Challenges for Promising Personalized Cancer Vaccine Motley Fool · November 3, 2026, 20:52 UTC
Amgen's Imdelltra Shows Significant Efficacy in Advanced Lung Cancer Treatment Motley Fool · November 2, 2026, 17:25 UTC
American Association for Physician Leadership Releases New Book on Systems Thinking and Strategic Change PR Newswire · October 30, 2026, 12:51 UTC